Canada regulates medical devices through Health Canada under the Food and Drugs Act and the Medical Devices Regulations (SOR/98-282). Devices are classified Class I to Class IV. Class I devices require only an MDEL (establishment licence) for the importer/distributor. Class II, III and IV devices require a Medical Device Licence (MDL) — and for the MDL, an MDSAP certificate is mandatory. If you already hold MDSAP for another market, Canada becomes one of the cheapest additional markets in the world.

By Tibor Zechmeister and Felix Lenhard.

TL;DR

  • Canada's medical device rules live in the Medical Devices Regulations (SOR/98-282) under the Food and Drugs Act .
  • Canada classifies devices I, II, III, IV — with Class I being lowest risk and Class IV highest (the opposite numbering direction from the EU MDR in risk terms, but the numbers themselves align once you understand the logic).
  • Class I devices do not need a Medical Device Licence. Class II, III, and IV devices do, and cannot be sold in Canada without one.
  • Since 1 January 2019, an MDSAP certificate is mandatory for any Class II, III, or IV MDL application. No other QMS evidence is accepted.
  • Health Canada licence applications are filed in English or French and use specific Canadian classification rules (Schedule 1 of SOR/98-282).
  • For a startup already holding an EU MDR CE certificate and MDSAP, Canada is typically faster and cheaper to enter than the US, and in the same league as Australia.

Why Canada is the market EU founders should not skip

Canada is a small market compared to the US or the EU. That is the reason founders skip it — and it is the wrong reason. Canada is a strategic market for three reasons:

First, it is a clean MDSAP market. Health Canada was the driver behind MDSAP becoming mandatory. That means if you want to sell a Class II device or higher in Canada, you must have an MDSAP certificate. If you plan correctly, the same MDSAP audit also covers the US, Brazil, Japan, and Australia in one visit. Canada forces the MDSAP decision and pays for it with four other markets.

Second, Canada's classification rules are rule-based like the EU's, which means your EU classification rationale is reusable with mapping. It is not aligned the way Australia's are, but the logic is familiar.

Third, Canada has public single-payer healthcare. Once you are listed, reimbursement pathways exist that do not look anything like the US private-payer maze. For certain device categories, Canada can become a real revenue market rather than a flag-on-the-map market.

The catch: MDSAP is not cheap and not fast. That is the commitment you are making when you add Canada.

What the Canadian framework actually says

The legal structure:

  • Food and Drugs Act — primary federal legislation.
  • Medical Devices Regulations (SOR/98-282) — the operational regulations for medical devices in Canada, including classification, licensing, labelling, and post-market obligations .
  • Schedule 1 of SOR/98-282 — the classification rules that assign devices to Class I, II, III, or IV based on invasiveness, duration of use, and other criteria.

Two separate licences exist:

  • MDEL (Medical Device Establishment Licence) — required for importers, distributors, and for manufacturers of Class I devices. It licences the establishment, not the device.
  • MDL (Medical Device Licence) — required before selling a Class II, III, or IV device in Canada. It licences the device itself.

For a Class II, III, or IV MDL, the manufacturer must submit, among other items, a valid MDSAP certificate from a recognised MDSAP Auditing Organisation. Since 1 January 2019, Canadian CMDCAS certificates are no longer recognised — MDSAP is the only accepted route .

MDSAP itself is based on ISO 13485:2016 plus the specific regulatory requirements of the five MDSAP regulatory authorities (Australia TGA, Brazil ANVISA, Canada Health Canada, Japan MHLW/PMDA, US FDA). A single MDSAP audit addresses all five.

A worked example: a Class III implantable from Graz

Imagine a Class III implantable device from a 12-person Austrian company. They hold:

  • CE mark under MDR Annex IX with a valid notified body certificate.
  • ISO 13485:2016+A11:2021 certificate issued by a notified body that is also an MDSAP Auditing Organisation.
  • Full MDR technical file, CER, PMS plan, PMCF plan.

To enter Canada:

  1. Confirm Canadian classification. A Class III implant under EU MDR typically lands in Canada Class III or IV depending on the specific rule. This must be mapped formally using Schedule 1 of SOR/98-282, not assumed.
  2. Commission an MDSAP audit (if not already held). Timing: 6–12 months to get scheduled, 4–6 weeks of internal prep, 3–5 days on-site, plus corrective actions. Plan a year in advance minimum.
  3. Prepare the MDL application. Contents include: device description, intended purpose, list of standards used, risk assessment summary, labels and instructions for use in English and French, manufacturer's attestation, summary of clinical evidence for Class III/IV, and the MDSAP certificate.
  4. Submit to Health Canada and pay the application fee (Class III/IV fees are substantial and increase annually).
  5. Respond to screening and review questions. Target Health Canada review timelines are published but real-world timelines vary by class and by device type.
  6. Appoint a Canadian Regulatory Correspondent if your company is outside Canada. This is not the same as a sponsor — the manufacturer is still the licence holder, but the regulatory correspondent is the contact point with Health Canada.
  7. Arrange an MDEL-holding importer to physically import the devices into Canada.

End-to-end, a Class III device from a well-prepared EU manufacturer with MDSAP already in place typically sees the MDL issued in 6–9 months from submission. Without MDSAP pre-existing, add 9–12 months.

The Subtract to Ship playbook for Canada

Step 1 — Decide on Canada by deciding on MDSAP. The only reason to delay Canada is if you are not yet ready for MDSAP. The only reason to accelerate Canada is if you are already doing MDSAP anyway. So the real decision is about MDSAP, not about Canada. See our dedicated post on the MDSAP startup decision.

Step 2 — Sequence the MDSAP audit to cover multiple markets at once. Do not do MDSAP just for Canada. Plan the single audit to generate evidence for Canada + Australia + Brazil + Japan + US simultaneously. The cost is roughly the same. The value is 5x.

Step 3 — Do the classification mapping as a formal document. Start a one-page classification justification per Schedule 1 of SOR/98-282. List every Canadian rule you considered, why it does or does not apply, and the final class. This document gets attached to the MDL application and pre-empts screening questions.

Step 4 — Budget for bilingual labelling. Canadian labels and IFUs must be in English and French. This is not optional, not negotiable, and not something you can resolve after submission. If you are redoing labels for Australia anyway, add French in the same sprint.

Step 5 — Choose your regulatory correspondent and importer carefully. The regulatory correspondent controls your line of communication with Health Canada. A good one answers screening questions before you see them. A bad one forwards PDFs with "please reply". The importer holds an MDEL and is your physical customs route.

Step 6 — Reuse your MDR technical file; do not rebuild it. Health Canada does not want your entire MDR technical file. They want specific sections mapped to their application format. Build a reverse-index from Canadian MDL requirements to your existing MDR technical file sections. Do not recommission clinical evaluations.

Step 7 — Plan for annual MDSAP surveillance and annual licence renewal. Neither is free. Both are predictable. Put both in your operating budget from year one.

Reality Check

  1. Do you currently hold an MDSAP certificate, or have you scheduled an MDSAP audit with a recognised Auditing Organisation?
  2. Have you mapped your device class to Schedule 1 of SOR/98-282 and written down the justification?
  3. For a Class III or IV device, have you identified the specific clinical evidence sections Health Canada will request, and confirmed your existing CER covers them?
  4. Have you appointed (or short-listed) a Canadian regulatory correspondent and an MDEL-holding importer?
  5. Have you prepared bilingual (English + French) labelling and instructions for use, or do you still have English-only?
  6. Have you budgeted the MDL application fees for your device class, plus annual right-to-sell fees?
  7. Have you aligned your MDSAP audit scope so the same audit can be used for other MDSAP markets in parallel?
  8. Do you have a post-market surveillance process that meets Health Canada's incident reporting timelines, which differ in detail from MDR Articles 87–92?

If more than two answers are "no", you are not ready to submit — you are ready to plan.

Frequently Asked Questions

Is MDSAP really mandatory for every Class II device in Canada? Yes. Since 1 January 2019, Health Canada accepts only MDSAP certificates as QMS evidence for Class II, III, and IV Medical Device Licence applications. ISO 13485 alone, without the MDSAP overlay, is not accepted.

Can I use my EU MDR notified body certificate in Canada? No, not as conformity assessment evidence. Canada has its own MDL system. Your EU certificate is useful context and your EU notified body may also be an MDSAP Auditing Organisation — but Health Canada assesses the MDL application on its own terms.

How much does MDSAP cost a startup? MDSAP audit fees depend on company size and scope but are typically several tens of thousands of euros per cycle, on top of your existing ISO 13485 costs. The economics only make sense if you are using MDSAP for multiple markets.

How long does a Class III MDL take once MDSAP is in hand? A clean Class III MDL application from an EU manufacturer with MDSAP already held typically takes 6–9 months to licence issuance. Class IV is longer because of the more extensive review.

Do I need a Canadian legal entity to hold an MDL? No. The manufacturer holds the MDL and can be outside Canada. You do need a Canadian regulatory correspondent for communication and an MDEL-holding importer for physical distribution.

What happens if my MDSAP certificate lapses? Your MDL is immediately at risk. Health Canada requires continuous MDSAP certification for the duration of the licence. A lapse means reporting obligations and potential licence suspension. MDSAP surveillance audits must be planned like notified body surveillance audits — non-negotiable.

Sources

  1. Food and Drugs Act (R.S.C., 1985, c. F-27), Government of Canada.
  2. Medical Devices Regulations (SOR/98-282), Government of Canada, as amended.
  3. Regulation (EU) 2017/745 on medical devices, consolidated text. Article 10, Annex IX.
  4. EN ISO 13485:2016+A11:2021 — Medical devices — Quality management systems — Requirements for regulatory purposes.
  5. IMDRF Medical Device Single Audit Program (MDSAP) regulatory authority documents.